Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report

Large cell neuroendocrine carcinoma (LCNEC) of the lung with epidermal growth factor receptor (EGFR) mutation is rare, and few cases have been treated with EGFR tyrosine kinase inhibitors (TKIs). We report the treatment of combined LCNEC with adenocarcinoma harboring an EGFR mutation with EGFR-TKIs...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Case Rep Oncol
Auteurs principaux: Muto, Satoshi, Ozaki, Yuki, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Shio, Yutaka, Hashimoto, Yuko, Suzuki, Hiroyuki
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2020
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7772843/
https://ncbi.nlm.nih.gov/pubmed/33442360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511112
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires